<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02763124</url>
  </required_header>
  <id_info>
    <org_study_id>CB-16-001</org_study_id>
    <nct_id>NCT02763124</nct_id>
  </id_info>
  <brief_title>Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions</brief_title>
  <official_title>Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gainesville Eye Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon, a Novartis Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Gainesville Eye Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce
      astigmatism in a pseudophakic population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of corneal arcuate incisions when
      they are performed with a femtosecond laser system on subjects who have had previous cataract
      surgery. The procedure to be used would not be different from that employed during cataract
      surgery, except that the only corneal incisions made would be the partial-depth arcuate
      incisions at the laser.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uncorrected monocular distance visual acuity</measure>
    <time_frame>60 days (+/- 10 days) after laser treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in corneal astigmatism</measure>
    <time_frame>60 days (+/- 10 days) after laser treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in refraction</measure>
    <time_frame>60 days (+/- 10 days) after laser treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence at distance</measure>
    <time_frame>60 days (+/- 10 days) after laser treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Verion-LenSx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Verion-LenSx femtosecond laser system will be used to perform one or two corneal arcuate incisions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Verion-LenSx</intervention_name>
    <description>The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions</description>
    <arm_group_label>Verion-LenSx</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40 or older

          -  Willing and able to provide informed consent for participation in the study.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clayton Blehm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gainesville Eye Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gainesville Eye Associates</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gainesville Eye Associates</investigator_affiliation>
    <investigator_full_name>Clayton Blehm</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Pseudophakic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Any shared data will be de-identified before sharing.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

